RAPS Sponsored Webcast: Efficient Personalization: Mastering Style Guides and Lexicons for Tailored Submissions On-Demand Webinar RAPS Sponsored Webcast: Efficient Personalization: Mastering Style Guides and Lexicons for Tailored Submissions Watch our RAPS-sponsored webinar to learn how style guides, lexicons, and automation improve regulatory writing…CertaraMay 30, 2025
What’s next for Trump’s ‘most favored nation’ policy? Press Coverage What’s next for Trump’s ‘most favored nation’ policy? The article discusses the latest developments in implementing President Donald Trump’s “most favored nation” policy,…Danielle PillsburyMay 27, 2025
‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented Blog ‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara Market…CertaraMay 23, 2025
Certara Reports First Quarter 2025 Financial Results Press Release Certara Reports First Quarter 2025 Financial Results RADNOR, PA— May 5, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…CertaraMay 5, 2025
Rare disease drug development: challenges, support and hopes for the future Press Coverage Rare disease drug development: challenges, support and hopes for the future Explore rare disease drug development challenges, biosimulation solutions, and IRDiRC's significant role in transforming the…CertaraApril 29, 2025
RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions On-Demand Webinar RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans Richardson…CertaraApril 24, 2025
Certara Announces Second Annual Certainty U.S. Event Announcement Certara Announces Second Annual Certainty U.S. Event Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…CertaraApril 22, 2025
Using cost-effectiveness models for smarter drug development and healthcare decisions Blog Using cost-effectiveness models for smarter drug development and healthcare decisions April 14, 2025 Editor’s note: This is the second in a series of four articles…CertaraApril 14, 2025
FDA to phase out animal testing with AI and lab-based models Press Coverage FDA to phase out animal testing with AI and lab-based models FDA aims to replace animal testing in drug development with AI and lab-based models, enhancing…CertaraApril 11, 2025